Ecoguided Genicular Nerve Block
Key facts
- Who runs it
- Hospital Universitario Fundación Alcorcón
- Where
- Spain1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 102 people enrolled
- Started
- 26 Apr 2023
- Ended
- 2 Nov 2024
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Genicular nerve block with bupivacaine and corticosteroids
- Genicular nerve block with bupivacaine
- Genicular nerve block with saline
- Record updated
- 27 April 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- Age over 18 years
- Anterior knee pain of patellofemoral origin and/or femorotibial compartment osteoarthritis with no previous response to pharmacological treatment (oral and/or topical)
- Pain duration of 3 months
- Pain assessment scale (Numerical Rating Scale) ≥ 5
- Radiological study with Kellgren-Lawrence classification > 2
Who cannot take part
- Patients who have undergone total or unicompartmental knee replacement surgery
- Viscosupplementation or intra-articular corticosteroid injection within the last 3 months
- Allergy to the active ingredients and excipients of: bupivacaine, triamcinolone, or saline solution
- Cognitive impairment or additional neuropsychiatric symptoms
- Failure to sign informed consent or revocation of it
- Patients with heart disease requiring blockade with levobupivacaine
- Pregnant women or those suspected of being pregnant
- Inability to write, speak, or read in Spanish
- Active tumoral or infectious pathology
- Osteoarthritis secondary to inflammatory pathology
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Osteoarthritis is a pathology with high prevalence in the world and is increasing due to sedentary lifestyles. Recent researches that claim for conservative treatment have shown the utility of genicular nerve blocks for relief of chronic knee pain.
Read full original descriptionShow less
Likewise, the ultrasound-guided technique has been more popular among professionals in recent years due to its low cost and safety.
This pilot study tries to evaluate if the infiltration of local anesthetic could avoid the use of corticosteroids with the secondary effects that they entail, therefore, it is carried out with the intention of estimating the size of the effect and the use of the variable response for later carrying out a clinical trial.
For this, we propose the comparative analysis of three randomized groups of patients (n=90), where all of them will perform a quadriceps strengthening exercise at home. Moreover, we will assess the reduction of pain through the visual analog scale (VAS) after the genicular nerve block with ultrasound-guided infiltration. Group 1 (n=30) will be infiltrated with local anesthetic and steroid, group 2 (n=30) with local anesthetic and group 3 (n=30), as a control group, will receive physiological saline. We will also record demographic data, functionality and mood using validated scales.
The 3 groups in the trial
- Group 1: Block with 0.5% bupivacaine and corticosteroid (triamcinolone).Existing treatment, for comparison
Injection Doses: 2.5 mL of 0.5% bupivacaine + 20 mg of triamcinolone.
Treatment: Genicular nerve block with bupivacaine and corticosteroids
- Group 2: Block with 0.5% bupivacaine.Existing treatment, for comparison
Injection Doses: 2.5 mL of 0.5% bupivacaine.
Treatment: Genicular nerve block with bupivacaine
- Group 3 (Control): Block with saline solution.Placebo, for comparison
Injection Doses: 2.5 mL of saline solution.
Treatment: Genicular nerve block with saline
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Ecoguided Genicular Nerve Block in Patients With Knee Osteoarthritis by Local Anesthetic or by Combination of Local Anesthetic and Corticoid: Placebo-Controlled Randomized Blind Clinical Trial
- Record updated
- 27 April 2025